持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/28 | 3,265 | 3,300 | 3,265 | 3,290 | +10 | +0.3% | 28,100 |
| 2024/02/27 | 3,230 | 3,300 | 3,230 | 3,280 | +40 | +1.2% | 46,100 |
| 2024/02/26 | 3,235 | 3,240 | 3,215 | 3,240 | +40 | +1.3% | 35,500 |
| 2024/02/22 | 3,180 | 3,205 | 3,170 | 3,200 | +20 | +0.6% | 35,200 |
| 2024/02/21 | 3,190 | 3,210 | 3,160 | 3,180 | -10 | -0.3% | 27,600 |
| 2024/02/20 | 3,175 | 3,210 | 3,175 | 3,190 | +15 | +0.5% | 22,600 |
| 2024/02/19 | 3,120 | 3,175 | 3,120 | 3,175 | +55 | +1.8% | 20,600 |
| 2024/02/16 | 3,105 | 3,145 | 3,095 | 3,120 | +50 | +1.6% | 44,800 |
| 2024/02/15 | 3,200 | 3,200 | 3,055 | 3,070 | -105 | -3.3% | 107,200 |
| 2024/02/14 | 3,255 | 3,260 | 3,170 | 3,175 | -65 | -2% | 47,400 |
| 2024/02/13 | 3,245 | 3,265 | 3,210 | 3,240 | +15 | +0.5% | 62,000 |
| 2024/02/09 | 3,205 | 3,230 | 3,195 | 3,225 | +10 | +0.3% | 26,900 |
| 2024/02/08 | 3,170 | 3,240 | 3,150 | 3,215 | +45 | +1.4% | 54,900 |
| 2024/02/07 | 3,165 | 3,185 | 3,145 | 3,170 | -5 | -0.2% | 49,200 |
| 2024/02/06 | 3,235 | 3,245 | 3,170 | 3,175 | -40 | -1.2% | 84,300 |
| 2024/02/05 | 3,335 | 3,380 | 3,145 | 3,215 | -120 | -3.6% | 136,500 |
| 2024/02/02 | 3,355 | 3,365 | 3,330 | 3,335 | +15 | +0.5% | 31,900 |
| 2024/02/01 | 3,300 | 3,335 | 3,280 | 3,320 | -30 | -0.9% | 36,200 |
| 2024/01/31 | 3,305 | 3,350 | 3,290 | 3,350 | +35 | +1.1% | 25,400 |
| 2024/01/30 | 3,365 | 3,365 | 3,310 | 3,315 | -20 | -0.6% | 30,200 |
| 2024/01/29 | 3,320 | 3,345 | 3,320 | 3,335 | +15 | +0.5% | 25,800 |
| 2024/01/26 | 3,310 | 3,345 | 3,290 | 3,320 | +10 | +0.3% | 37,600 |
| 2024/01/25 | 3,280 | 3,310 | 3,275 | 3,310 | +25 | +0.8% | 29,400 |
| 2024/01/24 | 3,300 | 3,315 | 3,260 | 3,285 | -30 | -0.9% | 30,600 |
| 2024/01/23 | 3,325 | 3,360 | 3,315 | 3,315 | -10 | -0.3% | 29,100 |
| 2024/01/22 | 3,350 | 3,360 | 3,320 | 3,325 | -5 | -0.2% | 19,700 |
| 2024/01/19 | 3,325 | 3,345 | 3,320 | 3,330 | +5 | +0.2% | 19,300 |
| 2024/01/18 | 3,350 | 3,350 | 3,320 | 3,325 | -20 | -0.6% | 25,100 |
| 2024/01/17 | 3,380 | 3,410 | 3,345 | 3,345 | -35 | -1% | 36,300 |
| 2024/01/16 | 3,420 | 3,430 | 3,370 | 3,380 | -30 | -0.9% | 22,300 |
| 2024/01/15 | 3,380 | 3,420 | 3,370 | 3,410 | +50 | +1.5% | 23,500 |
| 2024/01/12 | 3,415 | 3,415 | 3,350 | 3,360 | -40 | -1.2% | 24,700 |
| 2024/01/11 | 3,400 | 3,410 | 3,375 | 3,400 | +10 | +0.3% | 31,100 |
| 2024/01/10 | 3,375 | 3,405 | 3,330 | 3,390 | +35 | +1% | 38,200 |
| 2024/01/09 | 3,310 | 3,365 | 3,310 | 3,355 | +45 | +1.4% | 26,800 |
| 2024/01/05 | 3,330 | 3,335 | 3,295 | 3,310 | -15 | -0.5% | 21,000 |
| 2024/01/04 | 3,270 | 3,325 | 3,230 | 3,325 | +55 | +1.7% | 33,600 |
| 2023/12/29 | 3,295 | 3,295 | 3,260 | 3,270 | -15 | -0.5% | 15,800 |
| 2023/12/28 | 3,290 | 3,290 | 3,250 | 3,285 | +15 | +0.5% | 17,400 |
| 2023/12/27 | 3,225 | 3,275 | 3,225 | 3,270 | +25 | +0.8% | 29,100 |
| 2023/12/26 | 3,255 | 3,270 | 3,235 | 3,245 | +5 | +0.2% | 29,400 |
| 2023/12/25 | 3,260 | 3,270 | 3,230 | 3,240 | -45 | -1.4% | 21,000 |
| 2023/12/22 | 3,265 | 3,290 | 3,260 | 3,285 | +45 | +1.4% | 18,100 |
| 2023/12/21 | 3,245 | 3,260 | 3,240 | 3,240 | -15 | -0.5% | 18,400 |
| 2023/12/20 | 3,225 | 3,270 | 3,225 | 3,255 | +25 | +0.8% | 21,100 |
| 2023/12/19 | 3,265 | 3,270 | 3,215 | 3,230 | -30 | -0.9% | 24,800 |
| 2023/12/18 | 3,245 | 3,265 | 3,215 | 3,260 | +5 | +0.2% | 26,200 |
| 2023/12/15 | 3,330 | 3,330 | 3,255 | 3,255 | -55 | -1.7% | 44,000 |
| 2023/12/14 | 3,335 | 3,335 | 3,290 | 3,310 | +10 | +0.3% | 21,600 |
| 2023/12/13 | 3,295 | 3,325 | 3,280 | 3,300 | +5 | +0.2% | 16,900 |
51～
100
件表示中 / 3454件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 307,000円 | +3.0% | +27.5% | 2.61% | 19.43倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ネクセラファーマ | 157,800円 | +150.7% | - | 0.00% | 40.33倍 | 2.11倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ジーエヌアイ | 244,400円 | +52.1% | +23.3% | 0.00% | 17.27倍 | 3.61倍 |
|
創薬ベンチャー。米国で人工骨も。中国の特発性肺線維症薬で高シェア、米中に研究開発機能 |
| 鳥居薬 | 390,000円 | +7.3% | +16.8% | 3.08% | 23.33倍 | 0.91倍 |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
| 杏林製薬 | 174,300円 | +3.2% | +4.5% | 2.98% | 20.02倍 | 0.77倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
